179 related articles for article (PubMed ID: 28735466)
1. Comparative metabolic analysis in head and neck cancer and the normal gingiva.
Voelxen NF; Blatt S; Knopf P; Henkel M; Appelhans C; Righesso LAR; Pabst A; Goldschmitt J; Walenta S; Neff A; Mueller-Klieser W; Ziebart T
Clin Oral Investig; 2018 Mar; 22(2):1033-1043. PubMed ID: 28735466
[TBL] [Abstract][Full Text] [Related]
2. Lactate as a predictive marker for tumor recurrence in patients with head and neck squamous cell carcinoma (HNSCC) post radiation: a prospective study over 15 years.
Blatt S; Voelxen N; Sagheb K; Pabst AM; Walenta S; Schroeder T; Mueller-Klieser W; Ziebart T
Clin Oral Investig; 2016 Nov; 20(8):2097-2104. PubMed ID: 26728026
[TBL] [Abstract][Full Text] [Related]
3. Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer.
Curry JM; Tuluc M; Whitaker-Menezes D; Ames JA; Anantharaman A; Butera A; Leiby B; Cognetti DM; Sotgia F; Lisanti MP; Martinez-Outschoorn UE
Cell Cycle; 2013 May; 12(9):1371-84. PubMed ID: 23574725
[TBL] [Abstract][Full Text] [Related]
4. A reverse Warburg metabolism in oral squamous cell carcinoma is not dependent upon myofibroblasts.
Jensen DH; Therkildsen MH; Dabelsteen E
J Oral Pathol Med; 2015 Oct; 44(9):714-21. PubMed ID: 25420473
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia, metabolism, and growth factor signaling in head and neck squamous cell carcinoma: correlation between primary and xenograft tumors.
Stegeman H; Rademakers SE; Span PN; Takes RP; van der Kogel AJ; Kaanders JH; Bussink J
Head Neck; 2014 Sep; 36(9):1288-95. PubMed ID: 24668936
[TBL] [Abstract][Full Text] [Related]
6. Metabolic and proteomic differentials in head and neck squamous cell carcinomas and normal gingival tissue.
Ziebart T; Walenta S; Kunkel M; Reichert TE; Wagner W; Mueller-Klieser W
J Cancer Res Clin Oncol; 2011 Feb; 137(2):193-9. PubMed ID: 20383719
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of induced metabolic bioluminescence imaging in advanced ovarian cancer patients: first results of a pilot study.
Battista MJ; Goetze K; Schmidt M; Cotarelo C; Weyer-Elberich V; Hasenburg A; Mueller-Klieser W; Walenta S
J Cancer Res Clin Oncol; 2016 Sep; 142(9):1909-16. PubMed ID: 27342420
[TBL] [Abstract][Full Text] [Related]
8. [A preliminary study on the relationship between GLUT-1,MCT-4 and CAⅨ in laryngeal squamous cell carcinoma].
Wang YB; Xu O; Zhang RJ; Shan CG
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Apr; 31(7):510-514;519. PubMed ID: 29871299
[No Abstract] [Full Text] [Related]
9. Lactate-An Integrative Mirror of Cancer Metabolism.
Walenta S; Voelxen NF; Mueller-Klieser W
Recent Results Cancer Res; 2016; 207():23-37. PubMed ID: 27557533
[TBL] [Abstract][Full Text] [Related]
10. Characterization of miR-146a and miR-155 in blood, tissue and cell lines of head and neck squamous cell carcinoma patients and their impact on cell proliferation and migration.
Lerner C; Wemmert S; Bochen F; Kulas P; Linxweiler M; Hasenfus A; Heinzelmann J; Leidinger P; Backes C; Meese E; Urbschat S; Schick B
J Cancer Res Clin Oncol; 2016 Apr; 142(4):757-66. PubMed ID: 26621153
[TBL] [Abstract][Full Text] [Related]
11. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.
Zolk O; Schnepf R; Muschler M; Fromm MF; Wendler O; Traxdorf M; Iro H; Zenk J
Am J Pathol; 2013 Jan; 182(1):234-43. PubMed ID: 23137910
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of glycolysis markers in head and neck squamous cell carcinoma: a meta-analysis.
Wang Y; Li Y; Jiang L; Ren X; Cheng B; Xia J
Aging (Albany NY); 2021 Feb; 13(5):7284-7299. PubMed ID: 33653965
[TBL] [Abstract][Full Text] [Related]
13. Glucose metabolism in NSCLC is histology-specific and diverges the prognostic potential of 18FDG-PET for adenocarcinoma and squamous cell carcinoma.
Schuurbiers OC; Meijer TW; Kaanders JH; Looijen-Salamon MG; de Geus-Oei LF; van der Drift MA; van der Heijden EH; Oyen WJ; Visser EP; Span PN; Bussink J
J Thorac Oncol; 2014 Oct; 9(10):1485-93. PubMed ID: 25170642
[TBL] [Abstract][Full Text] [Related]
14. Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation.
Sáenz-de-Santa-María I; Bernardo-Castiñeira C; Secades P; Bernaldo-de-Quirós S; Rodrigo JP; Astudillo A; Chiara MD
Oncotarget; 2017 Feb; 8(8):13730-13746. PubMed ID: 28099149
[TBL] [Abstract][Full Text] [Related]
15. Adenosine metabolism of human mesenchymal stromal cells isolated from patients with head and neck squamous cell carcinoma.
Schuler PJ; Westerkamp AM; Kansy BA; Bruderek K; Dissmann PA; Dumitru CA; Lang S; Jackson EK; Brandau S
Immunobiology; 2017 Jan; 222(1):66-74. PubMed ID: 26898925
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tumor lactate oxidation: consequences for the tumor microenvironment.
Busk M; Walenta S; Mueller-Klieser W; Steiniche T; Jakobsen S; Horsman MR; Overgaard J
Radiother Oncol; 2011 Jun; 99(3):404-11. PubMed ID: 21704401
[TBL] [Abstract][Full Text] [Related]
17. Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis.
Chang YC; Chi LH; Chang WM; Su CY; Lin YF; Chen CL; Chen MH; Chang PM; Wu AT; Hsiao M
J Hematol Oncol; 2017 Jan; 10(1):11. PubMed ID: 28061796
[TBL] [Abstract][Full Text] [Related]
18. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.
Kakuki T; Kurose M; Takano K; Kondoh A; Obata K; Nomura K; Miyata R; Kaneko Y; Konno T; Takahashi S; Hatakeyama T; Kohno T; Himi T; Kojima T
Oncotarget; 2016 Jun; 7(23):33887-900. PubMed ID: 27036044
[TBL] [Abstract][Full Text] [Related]
20. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]